Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Molecular mimicry between viral antigens and host proteins can produce cross-reacting antibodies leading to autoimmunity. The coronavirus SARS-CoV-2 causes COVID-19, a disease curiously resulting in varied symptoms and outcomes, ranging from asymptomatic to fatal. Autoimmunity due to cross-reacting antibodies resulting from molecular mimicry between viral antigens and host proteins may provide an explanation. Thus, we computationally investigated molecular mimicry between SARS-CoV-2 Spike and known epitopes. We discovered molecular mimicry hotspots in Spike and highlight two examples with tentative high autoimmune potential and implications for understanding COVID-19 complications. We show that a TQLPP motif in Spike and thrombopoietin shares similar antibody binding properties. Antibodies cross-reacting with thrombopoietin may induce thrombocytopenia, a condition observed in COVID-19 patients. Another motif, ELDKY, is shared in multiple human proteins, such as PRKG1 involved in platelet activation and calcium regulation, and tropomyosin, which is linked to cardiac disease. Antibodies cross-reacting with PRKG1 and tropomyosin may cause known COVID-19 complications such as blood-clotting disorders and cardiac disease, respectively. Our findings illuminate COVID-19 pathogenesis and highlight the importance of considering autoimmune potential when developing therapeutic interventions to reduce adverse reactions.
Article activity feed
-
-
-
-
SciScore for 10.1101/2021.08.10.455737: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources One of these hits corresponded to the human thrombopoietin (hTPO) protein (Epitope ID: 920946, UniProt ID: P40225.1, residues 131-135: TQLPP), where the structural representative for hTPO was found bound to the TN1 Fab antibody (PDB id: 1V7M, [11]). human thrombopoietin (hTPO) protein (Epitope ID: 920946suggested: NoneThe contact area of the interface was calculated as (S1+S2-S12)/2, where S1 and S2 represent the solvent accessible surface areas of the antigen and antibody and S12 represents that for the complex (Fig. S12suggested: NoneUsing the MaSIF protocol, we evaluated complexes of the TN1 antibody … SciScore for 10.1101/2021.08.10.455737: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources One of these hits corresponded to the human thrombopoietin (hTPO) protein (Epitope ID: 920946, UniProt ID: P40225.1, residues 131-135: TQLPP), where the structural representative for hTPO was found bound to the TN1 Fab antibody (PDB id: 1V7M, [11]). human thrombopoietin (hTPO) protein (Epitope ID: 920946suggested: NoneThe contact area of the interface was calculated as (S1+S2-S12)/2, where S1 and S2 represent the solvent accessible surface areas of the antigen and antibody and S12 represents that for the complex (Fig. S12suggested: NoneUsing the MaSIF protocol, we evaluated complexes of the TN1 antibody to bind Spike protein in the TQLPP region. TN1suggested: NoneSoftware and Algorithms Sentences Resources To search EPI-SEQ, the amino acid sequence derived from PDB id 6XR8 (chain A) was used as the query in a local BLASTP search against EPI-SEQ using the BLOSUM62 matrix with both an E-value threshold and max target seqs value of 2,000,000, effectively turning off the E-value filter and removing the match limit, respectively. BLASTPsuggested: (BLASTP, RRID:SCR_001010)In summary, TM-align performed the structural superposition step based on the BLAST alignment, calculated RMSD, and a TM-align score. BLASTsuggested: (BLASTX, RRID:SCR_001653)Geometrical alignments, as well as visualization, were performed with PyMOL version 2.4 (33) and Visual Molecular Dynamics (VMD 1.9.3, (34)). PyMOLsuggested: (PyMOL, RRID:SCR_000305)Statistical analysis: Distributions were visualized as violin plots with ggpubr and ggplot2. ggplot2suggested: (ggplot2, RRID:SCR_014601)Statistical analysis comparing the different distributions was performed using Mann-Whitney U with Scipy, followed by a simplified Bonferroni correction (alpha/n comparisons) when appropriate. Scipysuggested: (SciPy, RRID:SCR_008058)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-